Korean Biotech Companies Pursue Open Innovation with Overseas Partners for Drug Discoveries
The Pulse News website reported that major Korean biotech companies have turned to open innovation with overseas partners for faster access to innovative methods and global markets. On July 13, JW Pharmaceutical signed an R&D partnership with ARCH Venture Partners in yet another unprecedented approach to open innovation following its joint research
Comments Off on Korean Biotech Companies Pursue Open Innovation with Overseas Partners for Drug Discoveries • Read this story »